Modified growth hormone fragment targeting fat metabolism without affecting IGF-1.
TL;DR — AOD9604 is a metabolic & weight peptide with a typical starting dose of 300 µg. For a 5 mg vial, add 1 mL bacteriostatic water to yield 5000 µg/mL.
Add 1 mL of bacteriostatic water to a 5 mg vial, injecting slowly down the inside wall. Swirl gently; never shake. This yields a concentration of 5000 µg/mL.
What is the recommended dose of AOD9604?
A typical research dose is 300 µg. Consult the ASCEND calculator for your specific vial concentration and draw volume.
How many doses are in a AOD9604 vial?
A 5 mg vial reconstituted with 1 mL BAC water yields approximately 16 doses at 300 µg each.
Peptide Intelligence
How does AOD9604 differ from growth hormone?
AOD9604 is a modified fragment of human growth hormone (hGH 176-191) containing the fat-metabolizing region without the growth-promoting or IGF-1-stimulating activity. It activates beta-3 adrenergic receptors and inhibits lipogenesis without affecting blood sugar.
What is the half-life of AOD9604?
AOD9604 has a short half-life of approximately 30 minutes to a few hours after subcutaneous injection. Most protocols use twice-daily administration to maintain activity throughout the day.
Does AOD9604 affect blood glucose or IGF-1?
Unlike intact growth hormone, AOD9604 does not measurably raise blood glucose or stimulate IGF-1 production. Phase 2 clinical trials confirmed it has no significant effect on these parameters, distinguishing it from growth hormone itself.